Chris Broomell

Company: Omega Therapeutics, Inc.

Job title: Director - Drug Product & Analytical Development

Seminars:

Roundtable discussion – Tackling Impurity Thresholds to Review the Required Target with an Appreciation of Degradation Impact 12:00 pm

Reviewing what ‘good’ looks like when striving for purity  Correlating impurity metrics with risk of degradation  Discussing realistic purity metrics to maximise control as well time efficiency Read more

day: Conference Day One